Håvard Midgard

7PUBLICATIONS
10CO-AUTHORS
PharmacogenomicsPreventative health careRespiratory diseasesCounselling, wellbeing and community servicesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 27, 2024
Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial.

Kristian Braathen Malme, Kathrine Stene-Johansen, Ingvild Klundby

|Jun 02, 2024
Treatment Completion and Sustained Virologic Response in the Context of Hepatitis C Virus Elimination: Time to Let Go of the Reins?

Håvard Midgard, Kristian B Malme, Ane-Kristine Finbråten

|Nov 22, 2023
Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial.

Håvard Midgard, Kristian Braathen Malme, Charlotte Meinich Pihl

|Apr 01, 2022
Peer support in small towns: A decentralized mobile Hepatitis C virus clinic for people who inject drugs.

Håvard Midgard, Ronny Bjørnestad, Maren Egeland

|Jun 01, 2021
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV).

Lars T Fadnes, Christer Frode Aas, Jørn Henrik Vold

|Jun 17, 2020
Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs.

H Midgard, A K Finbråten, K B Malme

Pageof 2

Frequent Collaborators

1 joint publications

Lars T Fadnes

1 joint publications

Christer Frode Aas

1 joint publications

Jørn Henrik Vold

1 joint publications

Rafael Alexander Leiva